Q3 2025 saw strong organic growth across all business units, with net revenues and EBITDA up over 5% year-over-year and upgraded 2025 guidance. Leverage dropped post-IPO, M&A pipeline remains robust, and regulatory/tax changes have minimal impact.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.